Optimizing Clinical Trials with Cutaneous Biomarkers in Neurodegenerative Diseases
Time: 12:00 pm
day: Conference Day One - Track Three
Details:
- Use of Syn-One Biomarker Technology to support study subject homogeneity, identify target engagement, and measure P-SYN deposition changes over time
- Detection, visualization, and quantification of cutaneous misfolded alpha-synuclein
- Highlight preliminary data and topline results in current trials
